Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
J Nucl Med Technol ; 51(2): 160-161, 2023 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-36599705

RESUMEN

Gastrosplenic fistula is a rare complication arising mainly secondary to involvement of the stomach or spleen by lymphoma. A delayed diagnosis is associated with high morbidity and mortality. We present a case of gastrosplenic fistula secondary to gastric and splenic involvement by diffuse large B-cell lymphoma with relevant imaging findings. The patient was successfully treated with surgical resection.


Asunto(s)
Fístula Gástrica , Linfoma de Células B Grandes Difuso , Enfermedades del Bazo , Humanos , Enfermedades del Bazo/complicaciones , Enfermedades del Bazo/cirugía , Fístula Gástrica/diagnóstico por imagen , Fístula Gástrica/etiología , Fístula Gástrica/cirugía , Linfoma de Células B Grandes Difuso/complicaciones , Linfoma de Células B Grandes Difuso/diagnóstico por imagen , Estómago
2.
Transl Lung Cancer Res ; 11(12): 2567-2587, 2022 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-36636417

RESUMEN

Background and Objective: Low and intermediate grade neuroendocrine tumors of the lung are uncommon malignancies representing 2% of all lung cancers. These are termed typical and atypical pulmonary carcinoid tumors. These can arise in the setting of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH). The presentation, workup, management and outcomes of patients with these tumors can overlap with more common lung cancers but differ in that many of these patients have a prolonged clinical course. The objective of this narrative review is to summarize the literature and provide evidence and expert-based algorithms for work up and treatment of pulmonary carcinoids and DIPNECH. Methods: A search of PubMed and Web of Science databases ending April 15, 2022, with the following keywords "lung carcinoid", "DIPNECH", "lung neuroendocrine," and "bronchopulmonary carcinoid". Key Content and Findings: Pulmonary carcinoid tumors benefit from a multidisciplinary approach. Pre-treatment imaging with contrast-enhanced computed tomography, and DOTATATE positron emission tomography is required. Surgical resection is the gold standard for curative intent, and possibly including sublobar resections. Patients can recur or develop new primaries thus emphasizing the importance of surveillance; national guidelines recommend at least a 10-year follow up. A growing body of literature support the use of endobronchial therapy, with long responses documented. Systemic therapy consists of everolimus, somatostatin analogs, peptide receptor radionuclide therapy, and chemotherapy. Diffuse idiopathic pulmonary neuroendocrine tumor cell hyperplasia is rare, but series suggest somatostatin analogs may confer clinical benefit. Conclusions: Pulmonary carcinoid tumors and DIPNECH are rare. Despite lack of regulatory approvals for advanced disease, multiple options are available but should be sequenced according to the clinical status and disease biology. Each patient should be discussed in a multidisciplinary setting and clinical trials should be considered if available.

4.
J Nucl Med ; 57(11): 1764-1770, 2016 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-27587704

RESUMEN

Lung inflammatory diseases contribute significantly to the socioeconomic burden of disease. Yet very few new, effective therapies for respiratory disease have been approved for use. A major contributing factor is the lack of biomarkers that can accurately quantify the lung inflammatory burden and can be used to understand the contribution of lung inflammation to loss in lung function. Molecular imaging approaches can detect and quantify the recruitment and activation of specific immune cells in lung inflammation. We review the clinical techniques used to image lung inflammation, provide an overview of clinical and emerging PET techniques for quantifying lung inflammation, and discuss potential clinical applications.


Asunto(s)
Aumento de la Imagen/métodos , Pulmón/diagnóstico por imagen , Pulmón/inmunología , Neumonía/diagnóstico por imagen , Neumonía/inmunología , Tomografía de Emisión de Positrones/métodos , Humanos , Pulmón/patología , Neumonía/patología , Reproducibilidad de los Resultados , Sensibilidad y Especificidad
5.
J Am Soc Nephrol ; 20(3): 545-53, 2009 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19158351

RESUMEN

Increased consumption of fructose may play an important role in the epidemic of metabolic syndrome and may presage the development of diabetes, cardiovascular disease, and chronic kidney disease. Once in the cell, fructose is phosphorylated by ketohexokinase (KHK), leading to consumption of ATP, formation of AMP, and generation of uric acid through xanthine oxidoreductase (XOR). This study aimed to examine the direct effects of fructose in human kidney proximal tubular cells (HK-2) and whether they are mediated by the fructose metabolism via KHK. At a similar concentration to that observed in peripheral blood after a meal, fructose induced production of monocyte chemotactic protein 1 (MCP-1) and reactive oxygen species in HK-2 cells. Knockdown of KHK by stable transfection with small hairpin RNA demonstrated that these processes were KHK dependent. Several antioxidants, including specific inhibitors of NADPH oxidase and XOR, prevented MCP-1 secretion. We detected XOR mRNA in HK-2 cells and confirmed its activity by identifying uric acid by mass spectrometry. Fructose increased intracellular uric acid, and uric acid induced production of MCP-1 as well. In summary, postprandial concentrations of fructose stimulate redox- and urate-dependent inflammatory mediators in proximal tubular cells.


Asunto(s)
Fructoquinasas/metabolismo , Fructosa/metabolismo , Mediadores de Inflamación/metabolismo , Túbulos Renales Proximales/metabolismo , Adenosina Trifosfato/metabolismo , Animales , Secuencia de Bases , Línea Celular , Quimiocina CCL2/biosíntesis , Cartilla de ADN/genética , Fructoquinasas/antagonistas & inhibidores , Fructoquinasas/genética , Fructosa/farmacología , Humanos , Túbulos Renales Proximales/efectos de los fármacos , Masculino , Síndrome Metabólico/etiología , Síndrome Metabólico/metabolismo , Oxidación-Reducción , ARN Mensajero/genética , ARN Mensajero/metabolismo , ARN Interferente Pequeño/genética , Ratas , Ratas Sprague-Dawley , Especies Reactivas de Oxígeno/metabolismo , Insuficiencia Renal Crónica/etiología , Insuficiencia Renal Crónica/metabolismo , Transfección , Ácido Úrico/farmacología , Xantina Deshidrogenasa/genética , Xantina Deshidrogenasa/metabolismo
6.
J Med Food ; 10(2): 337-44, 2007 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-17651071

RESUMEN

Epidemiological studies have shown that phytochemicals in fruits and vegetables may decrease the incidence of cancer. The antioxidant activity of phytochemicals may be partially responsible for the reduced cancer risk. In this study, the antioxidant activity of several phytochemicals was compared using two different antioxidant assays: the oxygen radical absorbance capacity (ORAC) assay, which measures the decrease in fluorescence decay caused by antioxidants, and the total oxyradical scavenging capacity (TOSC) assay, which measures the decrease in ethylene production caused by antioxidants. TOSC and ORAC values were measured for 11 different phytochemicals, and values were expressed as micromol of Trolox equivalents/mg. As expected, a correlation was seen between the TOSC values and the ORAC values (R2 = 0.60). Quercitin, maritime pine bark extract (Pycnogenol, Horphag Research Ltd., Geneva, Switzerland), grape skin extract, and green tea polyphenols had the highest overall antioxidant activity of the 11 phytochemicals measured. Lemon fruit and citrus bioflavonoids had the lowest overall antioxidant activity. Rutin and alpha-lipoic acid had low ORAC values but high TOSC values when compared to the other phytochemicals. The correlation between the in vitro TOSC and ORAC antioxidant assays suggests that both assays may be useful in identifying phytochemicals with high antioxidant activity.


Asunto(s)
Antioxidantes/análisis , Antioxidantes/farmacología , Depuradores de Radicales Libres/farmacología , Extractos Vegetales/farmacología , Especies Reactivas de Oxígeno/química , Cromanos/análisis , Citrus/química , Etilenos/metabolismo , Flavonoides/farmacología , Frutas/química , Fenoles/farmacología , Polifenoles , Rutina/farmacología , Té/química , Ácido Tióctico/farmacología , Vitis/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...